Pulsion Medical Systems SE (LTS:0NFX) ROCE % : 30.13% (As of Dec. 2022)

View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Pulsion Medical Systems SE's annualized ROCE % for the quarter that ended in Dec. 2022 was 30.13%.

Pulsion Medical Systems SE ROCE % Historical Data

The historical data trend for Pulsion Medical Systems SE's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsion Medical Systems SE ROCE % Chart

Pulsion Medical Systems SE Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

27.52

20.77

42.65

26.49

30.13

Pulsion Medical Systems SE Semi-Annual Data
	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
ROCE %	Get a 7-Day Free Trial															27.52	20.77	42.65	26.49	30.13

Pulsion Medical Systems SE ROCE % Calculation

Pulsion Medical Systems SE's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	7.416	/	( ( (31.387 - 7.65)	+	(33.923 - 8.434) )	/ 2 )
	=	7.416	/	( (23.737	+	25.489)	/ 2 )
	=	7.416	/	24.613
	=	30.13 %

Pulsion Medical Systems SE's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2022 )		(Q: Dec. 2021 )		(Q: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2022 )		(Q: Dec. 2021 )		(Q: Dec. 2022 )
	=	7.416	/	( ( (31.387 - 7.65)	+	(33.923 - 8.434) )	/ 2 )
	=	7.416	/	( ( 23.737	+	25.489 )	/ 2 )
	=	7.416	/	24.613
	=	30.13 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2022) EBIT data.

Pulsion Medical Systems SE (LTS:0NFX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Pulsion Medical Systems SE ROCE % Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pulsion Medical Systems SE (LTS:0NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hans-Riedl-Street 17, Feldkirchen, DEU, 85622

Website

http://www.pulsion.com

Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE (LTS:0NFX) Headlines

No Headlines